Pharmacokinetics of the ghrelin agonist capromorelin in a single ascending dose Phase-I safety trial in spinal cord-injured and able-bodied volunteers
Crossref DOI link: https://doi.org/10.1038/sc.2014.218
Published Online: 2014-12-02
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ellis, A G
Zeglinski, P T
Brown, D J
Frauman, A G
Millard, M
Furness, J B
Text and Data Mining valid from 2014-12-02
Article History
Received: 24 July 2014
Accepted: 30 October 2014
First Online: 2 December 2014
Competing interests
: The authors declare no conflict of interest.